NASDAQ:BCTX | Cash Flow Statement | BriaCell Therapeutics Corp.

Complete source-backed cash-flow history.

Available history
2021-07-31 to 2026-04-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-04-30-$7.16M
2026-01-31-$7.22M
2025-10-31-$8.2M-$7.7M-$75,000.00
2025-07-31-$8.09M-$8.13M-$7.39M$13.56M
2025-04-30-$6.13M
2025-01-31-$6.29M
2024-10-31-$5.8M-$6.96M-$75,000.00$11.96M
2024-07-31-$1.21M-$4.04M-$456,801.00
2024-04-30$1.72M
2024-01-31-$11.29M
2023-10-31$6M-$7.61M
2023-07-31-$2.42M-$10.92M$4M
2023-04-30-$4.9M
2023-01-31-$11.88M
2022-10-31-$1.11M$3,818.00-$3.54M-$47,294.00
2022-07-31-$450,352.00$3,819.00-$3.33M-$159,783.00
2022-04-30-$10.02M
2022-01-31$11.16M
2021-10-31-$27.53M$3,817.00-$1.78M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-07-31-$26.31M-$28.17M-$7.65M$45.45M
2024-07-31-$4.79M-$24.13M$456,801.00-$681,801.00$4.42M
2023-07-31-$20.3M-$23.74M$3.95M
2022-07-31-$26.84M$15,272.00-$12.48M-$3.74M
2021-07-31-$13.82M$15,256.00-$7.75M$65M